Small molecules in targeted cancer therapy: advances, challenges, and future perspectivesLei Zhong, Shengyong Yang|Signal Transduction and Targeted Therapy|2021Cited by 1.6k
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Yueshan Li et al.|Science|2021Cited by 449
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Huiping Shuai et al.|Nature Microbiology|2022Cited by 101
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitorYueshan Li, Shengyong Yang|Nature Communications|2022Cited by 98
PocketFlow is a data-and-knowledge-driven structure-based molecular generative modelYuanyuan Jiang, Shengyong Yang, Guo Zhang et al.|Nature Machine Intelligence|2024Cited by 86